Clinical Trials Directory

Trials / Completed

CompletedNCT06390202

Uterine Artery Diastolic Notching & Apelin-13 and 36

Investigation of the Relationship Between Uterine Artery Doppler Diastolic Notching and Serum Apelin-13 and Apelin-36 Concentrations Between the 11th and 14th Weeks of Pregnancy

Status
Completed
Phase
Study type
Observational
Enrollment
88 (actual)
Sponsor
Umraniye Education and Research Hospital · Other Government
Sex
Female
Age
18 Years – 39 Years
Healthy volunteers
Accepted

Summary

This study was conducted to investigate the relationship between diastolic notching on uterine artery Doppler and serum apelin-13 and 36 concentrations between 11 and 14 weeks of gestation.

Detailed description

Apelin-13 and apelin-36, which provide vasodilatation through a nitric oxide-dependent mechanism, also play a role in trophoblasts' survival, proliferation, and migration. Based on this, we aimed to investigate serum apelin-13 and apelin-36 concentrations in pregnant women with and without diastolic notch on uterine artery Doppler between the 11th and 14th weeks of pregnancy. We hypothesized that apelin-13 and apelin-36 might be associated with the formation of diastolic notch in uterine artery Doppler and serum apelin-13 and apelin-36 concentrations would be lower in the group with a notch in the uterine artery Doppler than in the group without a notch.

Conditions

Interventions

TypeNameDescription
OTHERno interventionthere is no intervention in this study

Timeline

Start date
2023-03-01
Primary completion
2023-10-30
Completion
2024-01-01
First posted
2024-04-30
Last updated
2024-04-30

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06390202. Inclusion in this directory is not an endorsement.